MSQ Ventures is a New York-based cross-border advisory firm that bridges the healthcare industries globally by offering our deep knowledge, strong network, and local insights into the China market. We provide comprehensive advisory services for our clients’ cross-border projects: market assessment, in/out-licensing, capital raising, joint ventures, and PR&IR. We currently have offices in New York (headquarter), Beijing, Shanghai, and Shenzhen.
MSQ Ventures was founded in 2016 by a group of Wall Street and biotech veterans with expertise in global healthcare industries. Our platform combines the strengths of a dedicated U.S. based research team, cross-border transaction execution team, and senior advisory team, with the resources of a large Chinese network of investors and industry leaders, KOLs, and government regulatory agencies.
Over the past several years, we have successfully managed advisory projects for more than 100 clients. From understanding key segments of the China healthcare market to identifying and vetting the high potential counterparties to negotiating deals aimed at maximizing value creation, our team focuses on results, prioritizes efficiency, and guides our clients through the entire process. At MSQ we value teamwork, integrity, professionalism, and always go above and beyond to ensure our clients’ success.